DevicePharm entered the industry of Marketing Consultants in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code , which describes it as a Marketing Consultants. For further clarification, the SIC classifies this business under the code and described it as a Marketing Consultants. The business provides service to the B2B market.
To acquire more information, please contact Clay Wilemon, Chief Executive Officer by calling (949) 271-1180 during business hours. You can also write to the business’ Single Location at 2100 Main Street, Suite 250, Irvine, California CA 92614. You can also visit the company’s website at devicepharm.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | DevicePharm |
| Representative: | Clay Wilemon, Chief Executive Officer |
| Place of Business: | 2100 Main Street, Suite 250, Irvine, CA 92614 |
| Contact Number: | (949) 271-1180 |
| Website: | devicepharm.com |
| Type of Service: | Marketing Consultants |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2002 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
DevicePharm is a company operating from Orange, California providing professional Marketing Consultants and relevant B2B variables. It was founded in 2002 and registered with the SIC code as Marketing Consultants, and with the NAICS code as Marketing Consultants.
With a current employee count of 1 to 4, DevicePharm has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Clay Wilemon, Chief Executive Officer at (949) 271-1180 for related queries, or to locate its Single Location using the coordinates 33.6817305,-117.8521802.
The Single Location can also be found at the street address 2100 Main Street, Suite 250 in Irvine, California 92614 and can be engaged online through the company website at devicepharm.com, the company Twitter , and Facebook page .